Navigation Links
Clostridium difficile Infection: Strategic Approaches for Better Outcomes
Date:6/15/2009

Complimentary Continuing Education Live Lectures for Healthcare Professionals

VOORHEES, N.J., June 15 /PRNewswire/ -- In recent years, the epidemiology of Clostridium difficile infection (CDI) has been changing. This trend may be the result of antimicrobial use, infection control practices, or other factors. It is critical for healthcare professionals to be aware of the epidemiology of this virulent pathogen and apply evidence-based principles for diagnosis, treatment, and prevention.

To address the need for current education on CDI, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring complimentary continuing education lectures conveniently located at medical institutions across the United States. This activity is supported by an educational grant from ViroPharma Incorporated and is accredited for physicians, pharmacists, and registered nurses.

Faculty for these lectures are leading experts in infectious diseases, gastroenterology, microbiology, epidemiology, and infection control.

Healthcare professionals can visit www.RMEI.com/CDILectures, e-mail CDILectures@RMEI.com, or call toll-free to 1-866-992-9940 to schedule a lecture.

"Robert Michael Educational Institute LLC is committed to providing healthcare professionals with opportunities for quality, innovative, and convenient continuing medical education," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, certified, and non-certified education. The goal of all certified RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
2. Clostridium difficile Infection: Current Challenges and Controversies
3. Germgards Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C difficile, and Influenza Virus
4. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
5. Strategic Diagnostics Updates Roth Conference Presentation Time
6. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
7. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
8. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
9. Genstar Names Michael Hurt to Its Strategic Advisory Board
10. Pharsight Expands Strategic Consulting Services Team
11. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... May 20, 2016 , ... The recent recall by Costco and Trader Joes ... News on May 12, 2016(1), demonstrates the need for faster and more cost effective ... firm, PathSensors, Inc. , PathSensor’s latest solution uses a biosensor technology ...
(Date:5/19/2016)... 19, 2016  AdvancedFlow Systems Inc. (AFS), a ... out of Maple Ridge, British Columbia ... its existing portfolio of contract manufacturing clients by ... with its sister companies Surround Technologies (STI) and ... industrial group that specializes in providing contract manufacturing ...
(Date:5/19/2016)... KS (PRWEB) , ... May 19, 2016 , ... ... contract research organization (CRO) has welcomed Abu Siddiqui as Director, Large Molecule & ... and executing biologics, vaccine and translational biomarker discovery studies for preclinical and clinical ...
(Date:5/19/2016)... , May 19, 2016 ... una sessione orale durante il 52 ° ... n. 8006)    - Le conclusioni dello ... riguarda i pazienti trattati, di cui il 90% presenta una ... sei mesi o più. Il settantadue per cento dei pazienti ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):